SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
SEC Accession No. 0001193125-11-309529
Filing Date
2011-11-14
Accepted
2011-11-14 10:11:01
Documents
21
Filing Date Changed
2011-11-14
Effectiveness Date
2011-11-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d255173ddefa14a.htm DEFA14A 385651
2 GRAPHIC g255173g08h65.jpg GRAPHIC 2378
3 GRAPHIC g255173g11g53.jpg GRAPHIC 166319
4 GRAPHIC g255173g16c56.jpg GRAPHIC 7877
5 GRAPHIC g255173g19t06.jpg GRAPHIC 3216
6 GRAPHIC g255173g19u18.jpg GRAPHIC 2727
7 GRAPHIC g255173g26n66.jpg GRAPHIC 2588
8 GRAPHIC g255173g34i31.jpg GRAPHIC 2477
9 GRAPHIC g255173g40r90.jpg GRAPHIC 130038
10 GRAPHIC g255173g42t69.jpg GRAPHIC 2271
11 GRAPHIC g255173g44o11.jpg GRAPHIC 2664
12 GRAPHIC g255173g46b90.jpg GRAPHIC 3446
13 GRAPHIC g255173g49v58.jpg GRAPHIC 2656
14 GRAPHIC g255173g51j04.jpg GRAPHIC 2643
15 GRAPHIC g255173g57q80.jpg GRAPHIC 3016
16 GRAPHIC g255173g64n06.jpg GRAPHIC 2558
17 GRAPHIC g255173g69v43.jpg GRAPHIC 2454
18 GRAPHIC g255173g74t23.jpg GRAPHIC 2345
19 GRAPHIC g255173g79u30.jpg GRAPHIC 79012
20 GRAPHIC g255173g83z96.jpg GRAPHIC 2370
21 GRAPHIC g255173g97n83.jpg GRAPHIC 2656
  Complete submission text file 0001193125-11-309529.txt   976200
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27570 | Film No.: 111198624
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1